Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Expert Opinion on Drug Discovery|June 1, 2012
Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular riskDavid R Janero, Loren Lindsley, Venkata Kiran Vemuri, et al.
Methods in Enzymology|July 29, 2017
Design and Synthesis of Cannabinoid 1 Receptor (CB1R) Allosteric Modulators: Drug Discovery ApplicationsAbhijit R Kulkarni, Sumanta Garai, David R Janero, et al.
Bioorganic & Medicinal Chemistry|October 16, 2020
Focused structure-activity relationship profiling around the 2-phenylindole scaffold of a cannabinoid type-1 receptor agonist-positive allosteric modulator: site-III aromatic-ring congeners with enhanced activity and solubilityPeter C Schaffer, Pushkar M Kulkarni, David R Janero, et al.
Current Topics in Medicinal Chemistry|February 20, 2007
Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiersSubhash P Khanapure, David S Garvey, David R Janero, et al.
Molecular Biosystems|May 14, 2010
Identification by nuclear magnetic resonance spectroscopy of an active-site hydrogen-bond network in human monoacylglycerol lipase (hMGL): implications for hMGL dynamics, pharmacological inhibition, and catalytic mechanismIoannis Karageorgos, Sergiy Tyukhtenko, Nikolai Zvonok, et al.
Methodist Debakey Cardiovascular Journal|November 10, 2016
Nucleic Acid Delivery for Endothelial Dysfunction in Cardiovascular DiseasesDipti Deshpande, David R Janero, Victor Segura-Ibarra, et al.
Biochemical and Biophysical Research Communications|April 29, 2009
Structural biology of human cannabinoid receptor-2 helix 6 in membrane-mimetic environmentsElvis K Tiburu, Sergiy Tyukhtenko, Lalit Deshmukh, et al.
Biochemical and Biophysical Research Communications|September 22, 2009
NMR solution structure of human cannabinoid receptor-1 helix 7/8 peptide: candidate electrostatic interactions and microdomain formationSergiy Tyukhtenko, Elvis K Tiburu, Lalit Deshmukh, et al.
Chemistry & Biology|November 2, 2010
hCB2 ligand-interaction landscape: cysteine residues critical to biarylpyrazole antagonist binding motif and receptor modulationRichard W Mercier, Ying Pei, Lakshmipathi Pandarinathan, et al.
The AAPS Journal|January 15, 2011
Human cannabinoid 1 GPCR C-terminal domain interacts with bilayer phospholipids to modulate the structure of its membrane environmentElvis K Tiburu, Sergiy Tyukhtenko, Han Zhou, et al.
Pageof 7